DAFNA Capital Management »

Health Sciences Acq Corp 2 shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Health Sciences Acq Corp 2 (OBIO) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Health Sciences Acq Corp 2

Tip: Access up to 7 years of quarterly data

All positions including Health Sciences Acq Corp 2 held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Health Sciences Acq Corp 2 by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $902k 364k 2.48

More positions owned by DAFNA Capital Management

Stereotaxis Com New (STXS)
Spdr S&p Biotech Etf Etf (XBI)
Revolution Medicines (RVMD)
Cytokinetics Com New (CYTK)
AtriCure (ATRC)
Merus N V (MRUS)
Ishares Nasdaq Biotech Indx Etf (IBB)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Arcus Biosciences Incorporated (RCUS)
Syndax Pharmaceuticals (SNDX)
Day One Biopharmaceuticals I (DAWN)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Health Sciences Acq Corp 2

Rtw Investments
Perceptive Advisors
Vanguard Group
Alyeska Investment Group
Pathstone Holdings
Affinity Asset Advisors
BlackRock
Knoll Capital Management
Geode Capital Management
Renaissance Technologies
Millennium Management
DAFNA Capital Management
Knott David M Jr
Charles Schwab Investment Management
AMH Equity

View all funds holding Health Sciences Acq Corp 2